Raptor Pharmaceutical Corp Stock
Equities
US75382F1066
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Managers | Title | Age | Since |
---|---|---|---|
Paul Hoelscher
DFI | Director of Finance/CFO | 59 | 16-10-24 |
Kim Lee
IRC | Investor Relations Contact | - | 14-10-22 |
Corporate Officer/Principal | 62 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregg Lapointe
CHM | Chairman | 65 | 14-12-31 |
Timothy Walbert
BRD | Director/Board Member | 57 | 11-04-10 |
Paul Hoelscher
DFI | Director of Finance/CFO | 59 | 16-10-24 |
1st Jan change | Capi. | |
---|---|---|
+8.84% | 114B | |
+11.47% | 104B | |
-12.75% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.15% | 17.89B | |
+8.33% | 14.28B | |
+34.69% | 12.55B |
- Stock Market
- Equities
- Stock